Plus Therapeutics, Inc., was originally incorporated as a California general partnership in July 1996 and was incorporated in Delaware in May 1997. The Company is an American healthcare company focused on the development and commercialization of precise diagnosis and targeted radiopharmaceuticals for central nervous system (" CNS ") cancers. CNSide Diagnostics, LLC, its wholly-owned subsidiary, develops and commercializes proprietary laboratory-developed tests, such as CNSide, designed to identify tumor cells that have metastasized to the central nervous system in cancer and melanoma patients.
